1
/
of
0
FDA Drug/Biologics Approval BLA 125057 S-356, ADALIMUMAB
FDA Drug/Biologics Approval BLA 125057 S-356, ADALIMUMAB
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 125057 S-356
Company: ABBVIE INC
Drug Name: HUMIRA
Active Ingredients: ADALIMUMAB
Strength: 40MG/0.8ML
Dosage Form/Route: VIAL
Action Date: 12/31/2002
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: ABBVIE INC
Drug Name: HUMIRA
Active Ingredients: ADALIMUMAB
Strength: 40MG/0.8ML
Dosage Form/Route: VIAL
Action Date: 12/31/2002
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details